Long-Term Durability of Tenofovir-Based Antiretroviral Therapy in Relation to the Co-Administration of Other Drug Classes in Routine Clinical Practice

BACKGROUND: In clinical trials, toxicity leading to tenofovir disoproxil fumarate (TDF) discontinuation is rare (3% by 2 years); however in clinical practice it seems to be higher, particularly when TDF is co-administered with ritonavir-boosted protease inhibitors (PI/r). Aims of this study were to...

Descripción completa

Detalles Bibliográficos
Autores principales: Costarelli, Silvia, Cozzi-Lepri, Alessandro, Lapadula, Giuseppe, Bonora, Stefano, Madeddu, Giordano, Maggiolo, Franco, Antinori, Andrea, Galli, Massimo, Di Perri, Giovanni, Viale, Pierluigi, d’Arminio Monforte, Antonella, Gori, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055315/
https://www.ncbi.nlm.nih.gov/pubmed/27716843
http://dx.doi.org/10.1371/journal.pone.0160761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055315/
https://www.ncbi.nlm.nih.gov/pubmed/27716843
http://dx.doi.org/10.1371/journal.pone.0160761

Ejemplares similares